- Home
- SNGX vs POLA Comparison
SNGX vs POLA Comparison
Compare SNGX & POLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNGX
- POLA
- Stock Information
- Founded
- SNGX 1987
- POLA 1979
- Country
- SNGX United States
- POLA United States
- Employees
- SNGX N/A
- POLA N/A
- Industry
- SNGX Biotechnology: Pharmaceutical Preparations
- POLA Industrial Machinery/Components
- Sector
- SNGX Health Care
- POLA Miscellaneous
- Exchange
- SNGX Nasdaq
- POLA Nasdaq
- Market Cap
- SNGX 6.5M
- POLA 4.3M
- IPO Year
- SNGX 1987
- POLA 2016
- Fundamental
- Price
- SNGX $1.28
- POLA $1.91
- Analyst Decision
- SNGX
- POLA
- Analyst Count
- SNGX 0
- POLA 0
- Target Price
- SNGX N/A
- POLA N/A
- AVG Volume (30 Days)
- SNGX 2.7M
- POLA 280.1K
- Earning Date
- SNGX 08-08-2025
- POLA 08-13-2025
- Dividend Yield
- SNGX N/A
- POLA N/A
- EPS Growth
- SNGX N/A
- POLA N/A
- EPS
- SNGX N/A
- POLA N/A
- Revenue
- SNGX $2,342.00
- POLA $13,918,000.00
- Revenue This Year
- SNGX N/A
- POLA N/A
- Revenue Next Year
- SNGX N/A
- POLA N/A
- P/E Ratio
- SNGX N/A
- POLA N/A
- Revenue Growth
- SNGX N/A
- POLA 8.08
- 52 Week Low
- SNGX $1.09
- POLA $1.53
- 52 Week High
- SNGX $8.55
- POLA $4.69
- Technical
- Relative Strength Index (RSI)
- SNGX 34.55
- POLA 62.97
- Support Level
- SNGX $1.09
- POLA $1.82
- Resistance Level
- SNGX $1.88
- POLA $1.97
- Average True Range (ATR)
- SNGX 0.14
- POLA 0.16
- MACD
- SNGX -0.01
- POLA 0.03
- Stochastic Oscillator
- SNGX 22.78
- POLA 33.70
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).
About POLA Polar Power Inc.
Polar Power Inc is engaged in designing, manufacturing, and selling DC power generators, renewable energy, and cooling systems for applications in the telecommunications market and, to a lesser extent, in other markets, including military, electric vehicle, marine, and industrial. The company's products include DC generators, backup DC generators, hybrid power systems, Li-Ion battery systems, Marine DC generators, and others. The company's geographical presence is in the United States, Canada, Australia and South Pacific Islands, Asia, Europe and Middle East, United Kingdom, Other North America, South Africa, and others.